Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 1,901–2,000 of 2,099
Potent inflammatory biomarkers in insulin resistance
Verma, S., Abbas, M., Talwar, A., Anand, S., Nayyar, A., Fatima, F., & Zahera, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13195-0.00012-0
Prabakaran, A. D., Chung, H.-J., McFarland, K. S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.28.586997
“%) of insulin-mediated glucose disposal and utilization in both humans and rodents [8; 9].”
Wang, W., Liu, Z., Liu, L., Han, T., Yang, X., & Sun, C. (2021) · Figshare · doi:10.6084/m9.figshare.16921757
Wang, W., Liu, Z., Liu, L., Han, T., Yang, X., & Sun, C. (2021) · Figshare · doi:10.6084/m9.figshare.16921763
Wang, W., Liu, Z., Liu, L., Han, T., Yang, X., & Sun, C. (2021) · Figshare · doi:10.6084/m9.figshare.16921751
Wang, W., Liu, Z., Liu, L., Han, T., Yang, X., & Sun, C. (2021) · Figshare · doi:10.6084/m9.figshare.16921769
Huang, Q., Ouyang, W., Du, X., Qin, X., Pi, Y., Wang, J., Wu, Y., & Liu, X. (2024) · Research Square · doi:10.21203/rs.3.rs-4265095/v1
Rashid, I., Nepa, R., Kumar, A., Kaur, N., Kumar, D. M., & Kaur, D. L. P. (2024) · International Journal of Pharmaceutical and Bio-Medical Science · doi:10.47191/ijpbms/v4-i4-24
Russell‐Guzmán, J., Silva, L. A. D., Cadagan, C., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4812357
Beck, E. A., Hetrick, B., Nassar, L. R., Turnbull, D. W., Dean, T. A., GANNON, M. A., Aagaard, K. M., Wesolowski, S. R., Friedman, J. E., Kievit, P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.17.594191
“Dysregulation of skeletal muscle insulin-signaling and metabolism is a hallmark of insulin resistance and an underlying cause of cardiometabolic diseases and the progression of age-associated dysfunction 12 .”
BackgroundCollaboration of alogliptin and pioglitazone: a double hit on the target
Салухов, В. В., Анатольевна, К. Е., & Ilyinskaya, Т. A. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-157
Neuromuscular Signal Transmission
Myers, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-47065-3_5
Sen, I., Smith, J. A. B., Caria, E., Savikj, M., Lian, K., Ellefsen, S., Zierath, J. R., & Krook, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.05.602204
Muscle Organoid and Assembloid Systems
Soydan, H. E., & Doğan, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/5584_2024_816 · Cited by 1
Correlation between muscle tissue and type 2 diabetes
Noga, R., Marcinkowska, J., Miśkiewicz, M., Ptak, J., Herc, A., Sawczuk, M., Koczkodon, K., Teska, V., Perłowski, J., & Krompiewski, M. (2024) · Quality in Sport · doi:10.12775/qs.2024.18.53366
Emerging imaging modalities for assessment of the diabetic foot
Pierre-Jerome, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13328-2.00010-6
Lyons, K., Carrillo, B. P., Dasar, L. T., Ifeyinwa, O. P., & Gabriel, B. M. (2024) · medRxiv · doi:10.1101/2024.11.13.24317280
“Skeletal muscle is responsible for the majority of postprandial glucose uptake and plays a major role in regulating glycaemia (DeFronzo & Tripathy, 2009).”
Muscle Glucose Metabolism in Metabolic Diseases
Eshima, H. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815313925124010003
The impact of bisphenol AF on skeletal muscle function and differentiation in vitro
Cui, M., Tzioufa, F., Bruton, J. D., Westerblad, H., & Kos, V. M. (2024) · Toxicology in Vitro · doi:10.1016/j.tiv.2024.105975 · Cited by 1
“Skeletal muscle, in particular, accounts for up to 80 % of postprandial glucose uptake through both insulin-dependent and independent pathways (DeFronzo and Tripathy, 2009; Roden and Shulman, 2019) and Abbreviations: BPA, Bisphenol A; BPAF, Bisphenol AF; BPS, Bisphenol S; BSA, Bovine serum albumin;…”
Obesity, gut bacteria, and the epigenetic control of metabolic disease
Guidi, L., Martínez‐Téllez, B., & Santos, C. P. O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18979-1.00013-7
Associations of Handgrip Strength, Walking Pace, and Genetic Risks With Incident Arrhythmias
He, P., Ye, Z., Liu, M., Zhang, Y., Zhou, C., Zhang, Y., Yang, S., & Qin, X. (2024) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000005036
“It not only directly maintains many important functions of the human body but also plays an important role in metabolism as a site of protein storage and glucose disposal (15,45).”
Herbal Anti Diabetic A Review Efficacy and Mechanisms
Shinde, K., Waghmare, S., Nikam, N. V., Chavan, S., & Lahare, P. (2025) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-23037
High-throughput assessment of exercise-induced adaptations and muscle function in health and ageingPreprint
Malita, A., Texada, M. J., Kubrak, O. I., Lassen, M., Skakkebaek, A. H., Bradic, I., Larsen, M. R., Ahrentløv, N., & Rewitz, K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.16.633393 · Cited by 1
Hussain, I. (2020) · American Diabetes Association eBooks · doi:10.2337/9781580406314.ch02
Zhang, X., Wang, L., Zhao, J., & Zhao, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.05.636660
“Skeletal muscle plays a pivotal role in metabolism, serving as a primary target for insulin and the predominant site for insulin-mediated glucose uptake in the postprandial state [50].”
Solianik, R., Jarutienė, L., & Brazaitis, M. (2025) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2025.104088
Stronger Together: How GLP-1 RAs and SGLT-2 Inhibitors Revolutionize Type 2 Diabetes Treatment
Sitarek, H., Tabeau, A., Prus, J., Pięta, J., Pawlik, A., Dudek, P., Łuczak, K., Ulicka, W., Chudzikowski, M., & Prokopiuk, A. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.80.59642 · Cited by 2
Hypoglycemic episodes exacerbate skeletal muscle insulin resistance in type 2 diabetes mellitus
Zufry, H., Rosdiana, R., Sucipto, K. W., Ekadamayanti, A. S., & Firdausa, S. (2025) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_388_24
“[8] Insulin resistance reduces tyrosine phosphorylation of insulin receptor substrates (IRS) 1 and IRS 2 while increasing serine/threonine phosphorylation.”
InfluentialJing, Y., Wang, G., Shi, R., Wen, W., Wang, W., Zhao, X., & Liang, G. (2025) · Engineered Regeneration · doi:10.1016/j.engreg.2025.05.001 · Cited by 2
Chung, G. C., Lee, J. W., & Kim, E. (2025) · Journal of Retina · doi:10.21561/jor.2025.10.1.56
The microRNA regulatory landscape of skeletal muscle-derived extracellular vesiclesPreprint
Kawamoto, Y., Yamaguchi, A., Ma, X., Fujino, H., & Maeshige, N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.02.657546
Lean body mass index and the risk of diabetes onset: A nationwide epidemiological cohort study
Aoyama, K., Kaneko, H., Azegami, T., Okada, A., Suzuki, Y., Meguro, S., Fujiu, K., Takeda, N., Morita, H., Takeda, N., et al. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70102 · Cited by 1
“In glucose metabolism, skeletal muscle is a major target organ for glucose uptake by the insulin signaling pathway and is closely associated with insulin resistance and glucose storage 18,19 .”
Quispe, T. L. B., Huillca, O. M. Y., Escobar, G. C. Z., & Ortiz, M. A. B. (2025) · Estudios y Perspectivas Revista Científica y Académica · doi:10.61384/r.c.a..v5i2.1323
Qi, H., Zhang, Z., Hou, T., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5363748
Fu, X., Zhang, Z., Jiang, L., Liao, Q., Xu, Y., Wang, Y., Cao, Z., Wang, J., Wei, X., Gao, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.15.665019
Das, S. (2025) · Research Square · doi:10.21203/rs.3.rs-7297145/v1 · Cited by 1
Miro1 Mediates Skeletal Muscle Insulin Resistance in Type 2 DiabetesPreprint
Heintz, E. C., Dantas, W. S., Taylor, A. L., Zunica, E. R. M., Belmont, K. P., Mey, J. T., Beyl, R. A., Vandanmagsar, B., Parry, H. A., Ajayi, P. T., et al. (2025) · medRxiv · doi:10.1101/2025.08.06.25333143
Jia, Z., Liu, X., Wang, Z., Bo, T., Liu, Z., & Zhang, Y. (2025) · Research Square · doi:10.21203/rs.3.rs-7324468/v1
Zhang, X., Wang, L., Zhao, J., & Zhao, H. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.08.007
Glycation of Myoglobin: A positive feedback loop reinforcing insulin resistance
Stacey, N., Silva, Z., Boorany, N., Palos, J. O., Potgieter, C., & Pieterse, L. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111752
Kim, J., Permpoon, U., Lee, J.-H., Kim, J. H., Kim, H. M., Jeon, J., Nam, T., & Kim, C. Y. (2025) · Molecules · doi:10.3390/molecules30183839
“In addition, muscle atrophy not only affects physical activity but also impacts systemic metabolism, as muscle tissue serves a large storage reservoir for energy [7].”
Increased Skeletal Muscle Oxidative Capacity Augments the Myokine Response to Whole Body Vibration
Broniec, M. N., Norland, K., Looney, J. C., Crandall, R. H., Thomas, J., Wang, X., & Harris, R. A. (2025) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003854 · Cited by 1
Insulin secretion: Functional biochemical aspects
Anastasiou, I. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00285-5
Blockade of the Proximal Pancreatic C Fiber Enhances Insulin Sensitivity in Rats
Kusunoki, M., Sato, D., Hisano, F., Tsutsumi, K., & Miyata, T. (2025) · Obesities · doi:10.3390/obesities5040075
“Moreover, GIR increases observed during the euglycemic clamp are reported as being largely attributable to glucose uptake in the skeletal muscle [19].”
Association of Body Composition with Insulin Resistance in a Middle-Aged Population
Zhou, K., Zhang, Y., Chen, M., Deng, Q., Kang, H., Li, K., Wu, Y., Zhang, J., Zhu, J., Zheng, T., et al. (2025) · Hormone and Metabolic Research · doi:10.1055/a-2691-0442 · Cited by 1
Ayala, J. E. (2025) · Diabetes · doi:10.2337/dbi25-0022 · Cited by 1
Ciotlos, D. L., Hanks, S. C., Varshney, A., Erdos, M. R., Manickam, N., Stringham, H. M., Orchard, P., Hill‐Burns, E. M., Narisu, N., Bonnycastle, L. L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.27.683567
Discovery of placental microRNAs associated with maternal insulin sensitivity during pregnancy
Majid, S., Soukar, I., White, F., Allard, C., Aguet, F., Ardlie, K., Florez, J. C., Edlow, A. G., Jacques, P., Karumanchi, S. A., et al. (2025) · Placenta · doi:10.1016/j.placenta.2025.10.021
Mamontova, A. (2025) · Qeios · doi:10.32388/41p0e4
Mitochondrial health and longevity: intermittent fasting’s impact on cellular energy production
Ghosh, S., Singh, K. K., Mishra, P. K., Sinha, J. K., & Mitra, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30060-8.00021-2 · Cited by 7
Errata ao artigo "Sarcopenia Pediátrica: O que Sabemos?"
Marques, M., & Baptista, F. (2025) · Acta Médica Portuguesa · doi:10.20344/amp.24225
Schlabs, F. L., Larsen, J. K., Kruse, R., Deshmukh, A. S., & See, P. D. F. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5847954
Lee, H.-R., Ko, M., Cha, S., & Lee, T. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14248653
“Despite sufficient insulin or IGF-1 levels, persistent hyperinsulinemia may cause receptor desensitization, thereby blunting anabolic signaling [37].”
Zhu, F., Gu, X. J., Tang, D., Xuan, Y., Wang, X., Wang, S., Gao, P. H., Shen, Y., & Lu, L. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04683-2 · Cited by 2
Zhong, Y., Chen, S., Pan, J., Niu, R., Du, J., Dong, Q., Liu, Y., Yao, Y., Lin, Y., Fang, H., et al. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110223
Koury, M. (2014) · The Scholarship East Carolina University's Institutional Repository (East Carolina University)
The Role of Mitochondria in the Metabolic Syndrome and Insulin Resistance
Marín-García, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4599-9_21
Telomere length in cardiovascular disease and type 2 diabetes
Salpea, K. D. (2011) · UCL Discovery (University College London) · Cited by 1
Additional file 1 of The older, the less potential benefit for type 2 diabetes from weight control
Zhou, Q., Sun, J., Wu, Z., Wu, W., Zhang, X., Pan, Q., Qi, H., Yuan, H., Shi, H., Cao, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19625444
Montori-Grau, M., Aguilar-Recarte, D., Zarei, M., Pizarro‐Delgado, J., Palomer, X., & Vázquez-Carrera, M. (2022) · Figshare · doi:10.6084/m9.figshare.19606690
Vieira‐Lara, M. A., Dommerholt, M. B., Zhang, W., Blankestijn, M., Wolters, J., Abegaz, F., Gerding, A., van der Veen, Y. T., Thomas, R., van Os, R. P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15086047
Li, H.-Y., Li, C.-F., Liu, C.-H., Chen, S.-C., Liu, Y.-F., Lv, Q.-H., & Zhang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26757154
Han, J.-Y., Park, M., & Lee, H.-J. (2023) · Figshare · doi:10.6084/m9.figshare.23740542
Li, H.-Y., Li, C.-F., Liu, C.-H., Chen, S.-C., Liu, Y.-F., Lv, Q.-H., & Zhang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26757139
Li, H.-Y., Li, C.-F., Liu, C.-H., Chen, S.-C., Liu, Y.-F., Lv, Q.-H., & Zhang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26757157
Han, J.-Y., Park, M., & Lee, H.-J. (2023) · Figshare · doi:10.6084/m9.figshare.23740539
Burton, M. A., Garratt, E. S., Hewitt, M., Sharkh, H. Y., Antoun, E., Westbury, L. D., Dennison, E. M., Harvey, N. C., Cooper, C. C., MacIsaac, J. L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26633514
Akar, E. A., Weill, L., Khoury, M. E., Caradeuc, C., Bertho, G., Boutary, S., Bézier, C., Clerc, Z., Sapaly, D., Bendris, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26731981
Akar, E. A., Weill, L., Khoury, M. E., Caradeuc, C., Bertho, G., Boutary, S., Bézier, C., Clerc, Z., Sapaly, D., Bendris, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26731990
Tang, J., Cai, X., Liu, A., Yu, N., & Wang, S. (2024) · Figshare · doi:10.6084/m9.figshare.25632885
Ke, J., Hu, X., Wang, C., & Zhang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21546885
Vieira‐Lara, M. A., Dommerholt, M. B., Zhang, W., Blankestijn, M., Wolters, J., Abegaz, F., Gerding, A., van der Veen, Y. T., Thomas, R., van Os, R. P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15086068
Li, H.-Y., Li, C.-F., Liu, C.-H., Chen, S.-C., Liu, Y.-F., Lv, Q.-H., & Zhang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26757142
Haghparast Azad, M., Niktab, I., Dastjerdi, S., Abedpoor, N., Rahimi, G., Safaeinejad, Z., Peymani, M., Forootan, F. S., Asadi-Shekaari, M., Nasr Esfahani, M. H., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19313503
Ke, J., Hu, X., Wang, C., & Zhang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21546891
Li, H.-Y., Li, C.-F., Liu, C.-H., Chen, S.-C., Liu, Y.-F., Lv, Q.-H., & Zhang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26757151
Li, H.-Y., Li, C.-F., Liu, C.-H., Chen, S.-C., Liu, Y.-F., Lv, Q.-H., & Zhang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26757148
Han, J.-Y., Park, M., & Lee, H.-J. (2023) · Figshare · doi:10.6084/m9.figshare.23740536
Li, H., Chen, W., Lin, X., Chen, W., Xie, T., Chen, K., Hou, S., & Li, H. (2023) · Figshare · doi:10.6084/m9.figshare.24548111
Li, H.-Y., Li, C.-F., Liu, C.-H., Chen, S.-C., Liu, Y.-F., Lv, Q.-H., & Zhang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26757136
Vieira‐Lara, M. A., Dommerholt, M. B., Zhang, W., Blankestijn, M., Wolters, J., Abegaz, F., Gerding, A., van der Veen, Y. T., Thomas, R., van Os, R. P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15086059
Ke, J., Hu, X., Wang, C., & Zhang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21546888
Akar, E. A., Weill, L., Khoury, M. E., Caradeuc, C., Bertho, G., Boutary, S., Bézier, C., Clerc, Z., Sapaly, D., Bendris, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26731987
Nair, S., Guanzon, D., Jayabalan, N., Lai, A., Scholz‐Romero, K., Croft, P. K., Ormazábal, V., Palma, C., Diaz, E., McCarthy, E. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15982264
Burton, M. A., Garratt, E. S., Hewitt, M., Sharkh, H. Y., Antoun, E., Westbury, L. D., Dennison, E. M., Harvey, N. C., Cooper, C. C., MacIsaac, J. L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26633517
Vieira‐Lara, M. A., Dommerholt, M. B., Zhang, W., Blankestijn, M., Wolters, J., Abegaz, F., Gerding, A., van der Veen, Y. T., Thomas, R., van Os, R. P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15086044
Li, Z., Liu, B., Tong, X., Ma, Y., Bao, T., Yue, J., & Wu, C. (2024) · Figshare · doi:10.6084/m9.figshare.25025902
Phytochemicals and metabolic disorders: managing diabetes, obesity, and metabolic syndrome
Srinivasa, U. M., Paramasivan, K., & Anitha, R. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26494-8.00004-5 · Cited by 2
Protector role of muscle quality against diabetes in non-elderly U.S. adults
Yao, X., Xiao, K., & Oo, H. K. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01828-w
Sullivan, B. P., Burton, L. C., Ellis, A., Kargl, C. K., Shera, D., Kuang, S., Markworth, J. F., & Gavin, T. P. (2026) · Experimental Physiology · doi:10.1113/ep092268
A Preoptic Neurocircuit That Modulates Metabolic FlexibilityPreprint
Roessler, J. M., Alkire, M., Nigrin, N. T., Wang, H., Reid, C. M., Cortopassi, M. D., Waite, M., Linnehan, B., Griffith, E. C., Madigan, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.15.699760
Thi, N. H. L., Park, J. H., Han, M. J., Kim, S. H., Kim, D., Kim, S. H., Kim, S. H., & Kang, K. S. (2026) · Applied Biological Chemistry · doi:10.1186/s13765-025-01078-7 · Cited by 1
“Efficient glucose uptake by skeletal muscle cells is required for adequate blood glucose levels and metabolic homeostasis [5].”
Xiao, D., Fu, J. R., Kim, A. T., Liyanage, N. M., Yang, F., & Jeon, Y. (2026) · BioFactors · doi:10.1002/biof.70081 · Cited by 3
“Impaired muscle glucose uptake, mediated by defects in insulin-dependent (PI3K/Akt/GLUT4) and insulin-independent (AMPK/GLUT4) pathways, is a hallmark of T2D [7].”
Persson, K. W., Fjeldsøe, C., Frandsen, L. W., Knudsen, J. R., Kwak, S. E., Wang, H., Voldstedlund, C. T., Leandersson, M. R., Witczak, C. A., Wojtaszewski, J. F. P., et al. (2026) · Diabetes · doi:10.2337/db25-0567 · Cited by 1
Physical Therapist Management of Diabetes Mellitus
Kareem, M., & Balogun, J. A. (2026) · Springer eBooks · doi:10.1007/978-3-031-86558-9_25
A full-length single nuclei transcriptomic atlas of human skeletal muscle insulin resistancePreprint
Whytock, K. L., Divoux, A., Vazquez, J., Hopf, M. E., Viggars, M. R., Gutierrez‐Monreal, M. A., Ruggiero, C. H., Jimenez, F. R., Morena, F., Krassovskaia, P. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.26.708250
“A primed infusion of [6,6-2H2] glucose was ran constantly throughout the HE clamp.”
InfluentialZheng, H., Li, Y., Zhang, Y., et al. (2026) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(26)61111-9
Pathophysiology, Biochemistry, and Molecular Landscape of Insulin Resistance in Type 2 Diabetes
Vorotnikov, A. V., Podkuychenko, N. V., & Shestakova, M. V. (2026) · Biochemistry (Moscow) · doi:10.1134/s0006297925604198 · Cited by 1
“These changes are considered major predisposing factors, whereas insulin resistance (IR) is regarded as the principal predictor and central pathophysiological feature of T2D [3-5].”
Aboelela, O., Asaad, S. A., Ajami, A.-M., Olca, J., Davies, S., Saad, J. A., Rizqou, S., Rubis, G. D., Dua, K., & Paudel, K. R. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101747
Long-term remission of impaired glucose tolerance in the finnish diabetes prevention study
Uusitupa, M., Valtanen, M., Lindström, J., & Tuomilehto, J. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113222
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.